返回
Developing a better flu vaccine
DOI:10.1016/s1473-3099(26)00467-6.png)
摘要
En
期刊
IF:
31
论文数:
8.0K
被引数:
4.0W
机构
引用论文
A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older一项关于MF59佐剂四价亚单位细胞源性灭活流感疫苗(aQIVc)在50岁及以上成年人中的免疫原性和安全性随机化Ⅱ期研究
VACCINE
IF3.5
Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confirmation studies高剂量细胞基质佐剂四价流感疫苗的免疫原性和安全性:随机、对照剂量探索与剂量确认研究的合并结果
Vaccine
IF3.5
Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis基于细胞的四价季节性流感疫苗的有效性: 系统评价和荟萃分析
VACCINES
IF3.4
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact推进流感疫苗:下一代候选疫苗及其对全球健康影响的综述
Vaccine
IF0
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic
Vaccine
IF0
没有更多内容

